Leesburg, VA, September 07, 2012 --(PR.com
)-- K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced the launch of the SERENGETI® Complex Spine Minimally Invasive Retractor System at the Scoliosis Research Society (SRS) 47th Annual Meeting in Chicago. SERENGETI Complex Spine brings K2M’s focus on complex spine and minimally invasive together into one system by providing surgeons the ability to address deformity, trauma, and tumor, while promoting tissue preservation.
SERENGETI Complex Spine features next generation instrumentation to perform complex reduction, controlled manipulation, and above-skin compression and distraction without compromising the option for direct visualization. The system provides the ability to attach and remove the Minimally Invasive Reduction Tunnels intraoperatively, combining the benefits of a traditional rigid system with the revolutionary benefits of the flexible, polymer SERENGETI Retractor.
According to Steven M. DeLuca, DO, MS, orthopedic surgeon with the Orthopedic Institute of Pennsylvania, “Spinal surgery, from the simplest to the most complex procedures, is dynamic and can change mid-course. SERENGETI Complex Spine allows for on-the-spot decision making, providing surgeons the option to attach or remove the Reduction Tunnels in-situ.”
SERENGETI features a screw-based method of retraction, allowing for a fixed position to the anatomy. This simplified design allows for one-step, percutaneous placement of the screw and retractor, providing improved access for rod introduction.
“This important advancement of our already well received SERENGETI Minimally Invasive Retractor System serves as the intersection of our innovation efforts by combining our core competency in deformity with our award-winning minimally invasive technology,” stated Eric Major, K2M’s President and CEO. “SERENGETI Complex Spine stands up to the challenge of addressing complex pathologies within a less invasive environment, resulting in more options for surgeons with the ultimate objective of improved outcomes for their patients.”
K2M, Inc. is the largest privately held spinal device company in the world focused on the research, development, and commercialization of innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures. The company is recognized as a global leader in providing unique technologies for the treatment of deformity, degenerative, trauma, and tumor spinal patients. K2M’s product development pipeline includes: spinal stabilization systems, minimally invasive systems, biologics, and other advancing technologies, such as motion preservation, annular repair, and nucleus replacement. Additional information is available online at www.K2M.com.
Find K2M on Facebook: https://www.facebook.com/K2MInc
Follow K2M on Twitter: http://twitter.com/K2MInc